2023 Q2 Form 10-Q Financial Statement

#000095017023017937 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $4.360M $4.583M $5.161M
YoY Change -7.63% -11.2% -18.18%
Cost Of Revenue $3.174M $3.240M $3.328M
YoY Change -0.91% -2.64% 2.68%
Gross Profit $1.186M $1.343M $1.833M
YoY Change -21.82% -26.73% -40.23%
Gross Profit Margin 27.2% 29.3% 35.52%
Selling, General & Admin $4.377M $4.361M $4.256M
YoY Change 5.9% 2.47% 36.63%
% of Gross Profit 369.06% 324.72% 232.19%
Research & Development $2.797M $2.942M $2.917M
YoY Change -6.14% 0.86% 21.59%
% of Gross Profit 235.83% 219.06% 159.14%
Depreciation & Amortization $429.0K $430.0K $179.0K
YoY Change -31.9% 140.22% -79.28%
% of Gross Profit 36.17% 32.02% 9.77%
Operating Expenses $7.174M $7.303M $7.173M
YoY Change 0.86% 1.81% 30.09%
Operating Profit -$5.988M -$5.960M -$5.340M
YoY Change 7.01% 11.61% 118.23%
Interest Expense $0.00 $3.000K
YoY Change -100.0% -40.0%
% of Operating Profit
Other Income/Expense, Net $215.0K $225.0K $3.402M
YoY Change -27.61% -93.39% 940.37%
Pretax Income -$5.773M -$5.735M -$1.938M
YoY Change 8.95% 195.92% -8.58%
Income Tax $144.0K $48.00K $61.00K
% Of Pretax Income
Net Earnings -$5.917M -$5.783M -$1.999M
YoY Change 10.1% 189.29% -9.63%
Net Earnings / Revenue -135.71% -126.18% -38.73%
Basic Earnings Per Share -$0.34 -$0.34 -$0.13
Diluted Earnings Per Share -$0.34 -$0.34 -$128.7K
COMMON SHARES
Basic Shares Outstanding 17.25M 17.24M 15.54M
Diluted Shares Outstanding 17.41M 17.24M 15.54M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.98M $23.72M $41.54M
YoY Change -49.08% -42.91% 182.59%
Cash & Equivalents $18.98M $23.72M $41.54M
Short-Term Investments
Other Short-Term Assets $1.363M $1.653M $1.872M
YoY Change -17.29% -11.7% -43.27%
Inventory
Prepaid Expenses
Receivables $3.992M $4.054M $4.324M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $24.33M $29.42M $47.74M
YoY Change -43.29% -38.36% 113.11%
LONG-TERM ASSETS
Property, Plant & Equipment $3.586M $3.398M $3.424M
YoY Change 11.09% -0.76% -67.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $512.0K $567.0K $586.0K
YoY Change -13.37% -3.24% -16.29%
Total Long-Term Assets $6.736M $7.571M $4.850M
YoY Change -22.24% 56.1% -57.08%
TOTAL ASSETS
Total Short-Term Assets $24.33M $29.42M $47.74M
Total Long-Term Assets $6.736M $7.571M $4.850M
Total Assets $31.07M $36.99M $52.59M
YoY Change -39.75% -29.65% 56.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $891.0K $1.208M $737.0K
YoY Change 24.09% 63.91% 47.4%
Accrued Expenses $875.0K $601.0K $852.0K
YoY Change 7.1% -29.46% 32.71%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $5.634M $6.135M $6.396M
YoY Change -19.18% -4.08% -50.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $1.015M $1.017M $1.075M
YoY Change 0.59% -5.4% -61.61%
Total Long-Term Liabilities $1.015M $1.017M $1.075M
YoY Change 0.59% -5.4% -73.78%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.634M $6.135M $6.396M
Total Long-Term Liabilities $1.015M $1.017M $1.075M
Total Liabilities $7.813M $9.009M $7.471M
YoY Change -29.06% 20.59% -55.79%
SHAREHOLDERS EQUITY
Retained Earnings -$334.0M -$328.1M -$306.1M
YoY Change 7.24% 7.19%
Common Stock $358.3M $357.1M $352.3M
YoY Change 1.49% 1.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $23.25M $27.99M $45.12M
YoY Change
Total Liabilities & Shareholders Equity $31.07M $36.99M $52.59M
YoY Change -39.75% -29.65% 56.04%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$5.917M -$5.783M -$1.999M
YoY Change 10.1% 189.29% -9.63%
Depreciation, Depletion And Amortization $429.0K $430.0K $179.0K
YoY Change -31.9% 140.22% -79.28%
Cash From Operating Activities -$4.051M -$3.692M -$4.582M
YoY Change 9.19% -19.42% 104.46%
INVESTING ACTIVITIES
Capital Expenditures $578.0K $0.00 $12.00K
YoY Change -241.32% -100.0% 100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$578.0K -$579.0K -$498.0K
YoY Change 41.32% 16.27% 16.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -94.00K 8.000K -194.0K
YoY Change 10.59% -104.12% -106.25%
NET CHANGE
Cash From Operating Activities -4.051M -3.692M -4.582M
Cash From Investing Activities -578.0K -579.0K -498.0K
Cash From Financing Activities -94.00K 8.000K -194.0K
Net Change In Cash -4.723M -4.241M -5.301M
YoY Change 12.35% -20.0% -1455.75%
FREE CASH FLOW
Cash From Operating Activities -$4.051M -$3.692M -$4.582M
Capital Expenditures $578.0K $0.00 $12.00K
Free Cash Flow -$4.629M -$3.692M -$4.594M
YoY Change 40.23% -19.63% 104.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001389002
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-35838
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Marin Software Incorporated
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4647180
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
845 Market Street
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 450
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94103
CY2023Q1 dei City Area Code
CityAreaCode
415
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
399-2580
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.001 Par Value Per Share
CY2023Q1 dei Trading Symbol
TradingSymbol
MRIN
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17248081
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23716000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27957000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4054000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4521000
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1653000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2016000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
29423000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
34494000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3398000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3213000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3606000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3844000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
567000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
533000
CY2023Q1 us-gaap Assets
Assets
36994000
CY2022Q4 us-gaap Assets
Assets
42084000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1208000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1011000
CY2023Q1 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3178000
CY2022Q4 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3513000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1749000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1645000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
6135000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6169000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1857000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2199000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1017000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1002000
CY2023Q1 us-gaap Liabilities
Liabilities
9009000
CY2022Q4 us-gaap Liabilities
Liabilities
9370000
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3844000
CY2023Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
503000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
142857000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
142857000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17240000
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17240000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
17226000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
17226000
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
17000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
17000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
357055000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
355996000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-328117000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-322334000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-970000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-965000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
27985000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
32714000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
36994000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
42084000
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4583000
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5161000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
3240000
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
3328000
CY2023Q1 us-gaap Gross Profit
GrossProfit
1343000
CY2022Q1 us-gaap Gross Profit
GrossProfit
1833000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2025000
CY2022Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1787000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2942000
CY2022Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2917000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2336000
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2469000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
7303000
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
7173000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5960000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5340000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
225000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3402000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5735000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1938000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
61000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5783000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1999000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5788000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1996000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17235000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17235000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15537000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15537000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
32714000
CY2023Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1069000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5783000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
27985000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
46258000
CY2022Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
29000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
883000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1999000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
45116000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5783000
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-1999000
CY2023Q1 us-gaap Depreciation
Depreciation
11000
CY2022Q1 us-gaap Depreciation
Depreciation
179000
CY2023Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
419000
CY2022Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
542000
CY2023Q1 mrin Amortization Of Deferred Costs To Obtain And Fulfill Contracts
AmortizationOfDeferredCostsToObtainAndFulfillContracts
94000
CY2022Q1 mrin Amortization Of Deferred Costs To Obtain And Fulfill Contracts
AmortizationOfDeferredCostsToObtainAndFulfillContracts
83000
CY2023Q1 mrin Forgiveness Of Paycheck Protection Program Loan
ForgivenessOfPaycheckProtectionProgramLoan
0
CY2022Q1 mrin Forgiveness Of Paycheck Protection Program Loan
ForgivenessOfPaycheckProtectionProgramLoan
-3117000
CY2023Q1 us-gaap Interest Expense
InterestExpense
0
CY2022Q1 us-gaap Interest Expense
InterestExpense
3000
CY2023Q1 mrin Gain Loss On Disposals Of Property And Equipment And Right Of Use Asset
GainLossOnDisposalsOfPropertyAndEquipmentAndRightOfUseAsset
0
CY2022Q1 mrin Gain Loss On Disposals Of Property And Equipment And Right Of Use Asset
GainLossOnDisposalsOfPropertyAndEquipmentAndRightOfUseAsset
-1000
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-4000
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-26000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1032000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
857000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-279000
CY2022Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
20000
CY2023Q1 mrin Increase Decrease In Operating Lease
IncreaseDecreaseInOperatingLease
0
CY2022Q1 mrin Increase Decrease In Operating Lease
IncreaseDecreaseInOperatingLease
134000
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
0
CY2022Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-83000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-734000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-291000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-232000
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-616000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
194000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-238000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-350000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1629000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3692000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4582000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12000
CY2023Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
579000
CY2022Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
486000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-579000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-498000
CY2023Q1 mrin Repayment Of Paycheck Protection Program Loan
RepaymentOfPaycheckProtectionProgramLoan
0
CY2022Q1 mrin Repayment Of Paycheck Protection Program Loan
RepaymentOfPaycheckProtectionProgramLoan
-203000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
10000
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12000
CY2023Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
18000
CY2022Q1 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
21000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
8000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-194000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22000
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-27000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4241000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5301000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
27957000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
47057000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23716000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
41756000
CY2023Q1 mrin Non Cash Forgiveness Of Paycheck Protection Program Loan
NonCashForgivenessOfPaycheckProtectionProgramLoan
0
CY2022Q1 mrin Non Cash Forgiveness Of Paycheck Protection Program Loan
NonCashForgivenessOfPaycheckProtectionProgramLoan
3117000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5783000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-18227000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-328117000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23716000
CY2021Q3 mrin Aggregate Offering Price
AggregateOfferingPrice
22800000
CY2022Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
1296000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
736000
CY2023Q1 mrin Provision For Doubtful Accounts Reductions To Expense
ProvisionForDoubtfulAccountsReductionsToExpense
-1000
CY2023Q1 mrin Allowance For Doubtful Accounts Receivable Write Offs And Other Deductions
AllowanceForDoubtfulAccountsReceivableWriteOffsAndOtherDeductions
157000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
580000
CY2023Q1 mrin Allowance For Potential Customer Revenue Credits
AllowanceForPotentialCustomerRevenueCredits
87000
CY2022Q4 mrin Allowance For Potential Customer Revenue Credits
AllowanceForPotentialCustomerRevenueCredits
110000
CY2023Q1 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q1 us-gaap Debt Instrument Payment Terms
DebtInstrumentPaymentTerms
the Company repaid the remaining outstanding balance of approximately $200 in February 2022.
CY2022Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
200000
CY2022Q1 us-gaap Other Noncash Income
OtherNoncashIncome
3117000
CY2023Q1 mrin Subscription Contracts Term
SubscriptionContractsTerm
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
511000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
189000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
700000
CY2023Q1 mrin Unsatisfied Performance Obligation On Subscription Contract Term
UnsatisfiedPerformanceObligationOnSubscriptionContractTerm
P1Y
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4583000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5161000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4583000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5161000
CY2023Q1 mrin Number Of New Customer
NumberOfNewCustomer
0
CY2022Q1 mrin Number Of New Customer
NumberOfNewCustomer
0
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4324000
CY2023Q1 mrin Deferred Costs To Fulfill Contracts Expected Period Of Benefit
DeferredCostsToFulfillContractsExpectedPeriodOfBenefit
P30M
CY2023Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2022Q1 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52711000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
52837000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
49313000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
49624000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3398000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3213000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
430000
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
721000
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1302000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1460000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
601000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
535000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
506000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
464000
CY2023Q1 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
741000
CY2022Q4 us-gaap Customer Refund Liability Current
CustomerRefundLiabilityCurrent
1016000
CY2023Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
28000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
38000
CY2023Q1 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3178000
CY2022Q4 mrin Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
3513000
CY2023Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
300000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3606000
CY2023Q1 us-gaap Restructuring Costs
RestructuringCosts
53000
CY2021Q3 mrin Aggregate Offering Price
AggregateOfferingPrice
22800000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1032000
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
857000
CY2023Q1 mrin Employee Stock Purchase Plan Expected Life
EmployeeStockPurchasePlanExpectedLife
P6M
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.060
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1431000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1908000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
477000
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3816000
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
210000
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3606000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1749000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1857000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
504000
CY2022Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1417000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
161000
CY2022Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2022Q1 us-gaap Sublease Income
SubleaseIncome
271000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5735000
CY2023Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2022Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5783000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1999000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
17235000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
17235000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15537000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15537000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.34
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.34
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3564000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1928000

Files In Submission

Name View Source Status
mrin-20230331_cal.xml Edgar Link unprocessable
mrin-20230331_lab.xml Edgar Link unprocessable
mrin-20230331_def.xml Edgar Link unprocessable
0000950170-23-017937-index-headers.html Edgar Link pending
0000950170-23-017937-index.html Edgar Link pending
0000950170-23-017937.txt Edgar Link pending
0000950170-23-017937-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mrin-20230331.htm Edgar Link pending
mrin-20230331.xsd Edgar Link pending
mrin-ex10_1.htm Edgar Link pending
mrin-ex10_2.htm Edgar Link pending
mrin-ex10_3.htm Edgar Link pending
mrin-ex31_1.htm Edgar Link pending
mrin-ex31_2.htm Edgar Link pending
mrin-ex32_1.htm Edgar Link pending
mrin-ex32_2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
mrin-20230331_pre.xml Edgar Link unprocessable
mrin-20230331_htm.xml Edgar Link completed
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending